Chemistry Home

Departmental Goals

Faculty

Courses

Research

Our Graduates

Werth Lecture

Science Academy

Majors/Minors

Neuroscience Minor

Honors in Chemistry

Instrumentation

GRE Preparation

Department History

Links

Previous Werth Lectures About the Werth Lecture

2008 Werth Lectures in Chemistry

Dr. Elias I. Michaelis

University Distinguished Professor and Chair

Department of Pharmacology and Toxicology

Director of Higuchi Biosciences Center and Center for Neurobiology and Immunology Research

University of Kansas, Lawrence

Thur, Feb 7, 2008, 7pm 

RESEARCH LECTURE, Jones 212 "Life Among Neurons: Excitation, Alcoholism, Aging, and Neurodegeneration"

Fri, Feb 8, 2008, 3pm

CHEMISTRY CAREERS SESSION, Ivers 386 "Graduate Education and Research in the Biomedical Sciences in the 21st Century:  The Best of Times, the Most Challenging of Times"


Dr. Elias K. Michaelis is a University Distinguished Professor, Chairman of the Pharmacology and Toxicology Department and Director of Higuchi Biosciences Center and Center for Neurobiology and Immunology Research at the University of Kansas.  He received his B.S. in biology in 1966 from Fairleigh Dickinson University, his M.D. in 1969 from St. Louis University, and his Ph.D. in physiology and biophysics-neurochemistry in 1973 from the University of Kentucky.  As director of the Higuchi Biosciences Center, Dr. Michaelis helps foster research that may lead to answers about the bases of diseases such as cancer, heart disease and neurological disorders.  He directs the design of therapeutic agents and investigation of basic chemical and biological phenomena relevant to the biomedical sciences.  Professor Michaelis and his research group have been studying the brain proteins that function as receptors for the neurotransmitters L-glutamic and L-aspartic acid in mammalian brains. These proteins control excitability and viability of nerve cells under several conditions and pathologic states such as Huntington's disease, alcoholism, or Alzheimer's disease.  Experimental approaches include: Isolation and characterization of proteins that have the characteristics of NMDA receptors; production of polyclonal and monoclonal antibodies for topographic and molecular studies; sequencing of proteins; synthesis of cDNA probes; study of expression of receptor proteins under physiologic and pathologic conditions; reconstitution of receptors in liposomes and measurement of ion channel activity by rapid kinetic instrumentation and patch clamp techniques.  More recent studies are focused on the steps of signal transduction in neurons and the modification produced by chronic alcoholism, oxidation and aging.  Dr. Michaelis travels the world presenting and participating in many scientific conferences including the Drug Discovery for Neurodegeneration Conference.